Jinhan Kim ^UDM

Jinhan Kim, as CEO and Co-founder of Standigm Inc., is leading the company in AI-driven drug discovery with a focus on workflow automation. Standigm's proprietary AI platforms, including DarkMolFactory™, are designed to enhance the entire drug discovery process, from target identification to lead generation. Kim's vision and leadership have been instrumental in Standigm's success in producing First-in-Class lead compounds and expanding AI automation in drug discovery.